Can a phone app help women at risk of HIV start PrEP?

NCT ID NCT06853314

Recruiting now Prevention Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a mobile health program called WINGS+PrEP for women who have experienced heavy drinking, partner violence, and involvement with the criminal legal system. The program provides information about PrEP (a daily pill that prevents HIV) and offers support sessions. Researchers want to see if this approach helps more women start and stay on PrEP compared to standard care. The trial will enroll 307 HIV-negative women and follow them for 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (mobile health program with PrEP decision aid and peer navigation)
What this could lead to: If it works, this could provide an effective way to increase PrEP use and reduce HIV risk among women facing heavy alcohol use and partner violence.
What could go wrong: This is a behavioral intervention, not a drug, so results depend on participant engagement. The trial is relatively small (307 people) and may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER HIV INFECTIONS VIOLENCE, GENDER-BASED

Contacts and locations

Locations

The Columbia Community Partnership for Health
RECRUITING

New York, New York, 10033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.